IDH2 and glioma: In vivo studies comparing mutant IDH glioma biopsies to wild-type IDH GBM biopsies also showed lower glutamate levels, in spite of the vastly disparate genetic landscape of these tumor types, but trends in other metabolites were more complex 40.